Building Supply Chain Resilience During COVID-19 with Real-Time Visibility Technology
As the industry has been left scrambling to ensure continuity and minimize disruptions during the pandemic, a greater focus on visibility, transparency, and agility is becoming the new normal.
The COVID-19 pandemic has stressed the global pharmaceutical supply chain in unimaginable ways. As the industry has been left scrambling to ensure continuity and minimize disruptions, a greater focus on visibility, transparency, and agility is becoming the new normal.
Gain actionable insights into how real-time monitoring helped track COVID-19 test kits
Drawing from an actual example demonstrating how real-time monitoring has helped Ipsos MORI, a global market research firm, track location and quality conditions of tens of thousands COVID-19 test kits throughout the UK, attendees will take away a better understanding of and actionable insights into:
How real-time visibility has helped mitigate supply chain risk during the pandemic
How stakeholder collaboration and data sharing is key to achieving supply chain resilience
How monitoring technology will help to further automate logistics processes
What the post-pandemic supply chain will look like
The presenters
Kelly Beaver, Managing Director, Ipsos MORI
Ada Palmadottir, MPharm, MBA, Director of Pharmaceutical Validation and Compliance, Controlant
